Company Filing History:
Years Active: 2011-2012
Title: Craig Dorrell: Innovator in Monoclonal Antibodies
Introduction
Craig Dorrell is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, his work has the potential to impact medical diagnostics and treatment.
Latest Patents
Dorrell's latest patents focus on isolated monoclonal antibodies that specifically bind to cell surface antigens expressed on human pancreatic endocrine and exocrine cells. These antibodies can be utilized to detect and isolate pancreatic cells, which is crucial for diagnosing conditions such as diabetes and pancreatic tumors. The patents also describe methods for treating pancreatic tumors using these antibodies, which can be conjugated to effector molecules or detectable markers.
Career Highlights
Craig Dorrell is affiliated with Oregon Health & Science University, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential applications in treating pancreatic diseases and improving patient outcomes.
Collaborations
Dorrell has collaborated with notable colleagues, including Markus Grompe and Philip R. Streeter, to advance research in monoclonal antibodies and their therapeutic uses.
Conclusion
Craig Dorrell's contributions to the field of monoclonal antibodies exemplify the importance of innovation in medical research. His patents and ongoing work continue to pave the way for advancements in the diagnosis and treatment of pancreatic conditions.